Short Courses and Presentations by Dr. Purcell
“Strategy of Drug Design,” November 7-9, 1976. Ciba-Geigy. Schauenberg, Switzerland.
“Strategy of Drug Design,” January 19, January 26, February 2, and February 9, l977. Ciba-Geigy. Basle, Switzerland.
“QSAR in Pesticide Design,” October 26-28, 1977. “Short Course on QSAR, “ November 19-20, 1981. “Short Course on QSAR,” April 18-19, 1984. FMC Corporation, Princeton, New Jersey.
“Short Course on QSAR,” April 10,11,14, 1978. L’Oréal, Paris, France.
“Short Course on QSAR,” April 26-28, 1978. Apotekarsocieteten, Stockholm, Sweden.
“Short Course on QSAR,” April 8-20, 1979. Riyadh University, Riyadh, Saudi Arabia.
“Short Course on QSAR,” January 28-February 1, 1980. BASF, Ludwigshafen, West Germany.
“Short Course on QSAR,” April 27-28, 1982. Synthelabo, Paris, France.
National and International Scientific Meetings:
International Conference on Structure and Reactions of DFP-Sensitive Enzymes, 1966, Stockholm, Sweden.
Institute in Quantum Chemistry, Solid State Physics, and Quantum Biology, 1966, 1968-1976, 1978-1981, Sanibel Island, Florida.
Gordon Research Conference on Toxicology and Safety Evaluations, 1968, Crystal Mountain, Washington.
Walter Reed Army Institute of Research, Department of Molecular Biology, Research Symposium on Complexes of Biologically Active Substances with Nucleic Acids and Their Modes of Action, 1970, Washington, D.C.
Joint meeting of the American Chemical Society, Division of Medicinal Chemistry, and the American Society for Pharmacology and Experimental Therapeutics, “Introduction to Molecular Orbital Theory,” August 24, 1971, Burlington, Vermont.
Gordon Research Conference on Medicinal Chemistry, section on Theoretical Chemistry and Drug Design, “New Work on the Correlation of Electronic Structure and Physicochemical Parameters with Biological Activity,” August 9-13, 1971, Colby Jr. College, New London, New Hampshire.
3rd International Symposium on Medicinal Chemistry, organized by the Italian Society of Pharmaceutical Sciences, sponsored by the International Union of Pure and Applied Chemistry (Section on Medicinal Chemistry), September 11-15, 1972, Milan, Italy.
Keynote address presented at the Prague Conference on Chemical Structure-Biological Activity Relationships: Quantitative Approaches, under the auspices of the Czechoslovak Medical Society, J.D. Purkyne, Institute of Hygiene and Epidemiology, Department of Industrial Hygiene and Occupational Diseases, the Czechoslovak Chemical Society, and the International Society of Quantum Biology, June 26-29, 1973, Prague, Czechoslovakia.
First International Congress of Quantum Chemistry, July 2-10, 1973, Menton, France.
National Institutes of Health Symposium “Structure-Activity Techniques in the Treatment of Antitumor Drug Data,” National Institutes of Health, March 4, 1974, Bethesda, Maryland.
The VIIth Jerusalem Symposium, “Molecular and Quantum Pharmacology,” sponsored jointly by the Hebrew University, Jerusalem, Israel, and the Institute de Biologie Physico-Chimique (Foundation Edmond de Rothschild), Paris, France, and presented lecture “Quantitative Structure-Activity Relationships: An Approach to Drug Design,” March 25-April 4, 1974, Jerusalem, Israel.
The Sandoz Symposium, “Drug-Receptor Interactions in Antimicrobial Chemotherapy,: sponsored by SANDOZ Forschungsinstitut Ges.m.b.m. Chairman of session, “Receptor Hypothesis,” and presented lecture “Strategy of Drug Design,” September 4-6, 1974, Vienna, Austria.
Gordon Research Conference on Quantitative Structure-Activity Relationships in Biology, Discussion leader of session, “Special Contributions,” June 30-July 4, 1975, Franklin Pierce College, Rindge, New Hampshire.
Xie Recontres Interationales De Chimie Therapeutique, invited lecturer, September 10-12, 1975, Université de Montpellier, Montpellier, France.
International Symposium in Honor of Per-Olov Löwdin, “Future of Quantum Chemistry,” Norwegian Academy of Sciences and University of Uppsala, September 2-4, 1976, Dalseter, Norway.
Symposium International, “Frontieres en Biologie Physico-Chimique,” Institut de Biologie Physico-Chimique, May 23-27, 1977, Paris, France.
Gordon Research Conference on Quantitative Structure-Activity Relationships in Biology, Discussion leader of session, “New View of QSAR,” July 18-22, 1977, Plymouth State College, Plymouth, New Hampshire.
IUPAC-IUPHAR Symposium, “Biological Activity and Chemical Structure,” Round table moderator and contributor, “The Development of Bioactive Compounds: A Multidisciplinary Approach,” August 30-September 2, 1977, Noordwijkerhout, The Netherlands.
International Workshop on Drug Design, “Techniques for Selecting Substituent Groups for Molecular Modification in Drug Design,” April 21, 1978, Roam, Italy.
Workshop on Structure-Activity Concepts in Environmental Sciences, “Available Methods for Structure-Activity: Requirements and Limitations,” U.S. Environmental Protection Agency, February 1-4, 1981, San Antonio, Texas.
Structure-Activity Correlation as a Predictive Tool in Toxicology, “Quantitative Structure-Mutagenicity Relationships,” February 10-12, 1981, Raleigh, North Carolina.
Gordon Research Conference on Quantitative Structure-Activity Relationships, July 13-17, 1981, Plymouth State College, Plymouth, New Hampshire.
Gordon Research Conference on Quantitative Structure-Activity Relationships, July 25-29, 1983, Plymouth State College, Plymouth, New Hampshire.
Since 1964, has presented 76 invited lectures throughout the United States and in Sweden, Spain, Czechoslovakia, Switzerland, France, West Germany, East Germany, Saudi Arabia, and England primarily in the area of designing biologically safe and effective compounds for medicine and agriculture.
Let's Talk About Your Project
Molecular Design International, Inc.
changing the world,
one molecule at a time
© 2016 Molecular Design International, Inc.
Connect and Follow
1138 North Germantown Parkway
Cordova, TN 38016
Phone (901) 747-3366
Fax (901) 747-5606